Palo Alto Investors LP
PALO ALTO, CA · CIK 1306923 · 13F filing filed 2022-08-15
SEC-registered investment adviser since 2000 · limited partnership
- Assets managed$696.0m
- Staff10 · 4 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds6 (6 hedge) · $692.0m gross assets
- Websitepa-investors.com
- Form ADV · 2026-03-27SEC adviser record
- Legal entityPalo Alto Investors LP (US)
- Kindhedge funds
- Others nearbyPalo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 6
$1.1bn
reported value
-11.3% vs Q1 2022
33positions
82.8%in top 10
0 new
1 added
10 reduced
2 sold out
vs Q1 2022
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC BMRN | $170.8m14.89% | Reduced -78.2k |
| UNITED THERAPEUTICS CORP DEL UTHR | $149.6m13.04% | Reduced -18.3k |
| ABIOMED INC ABMD | $122.4m10.67% | Unchanged |
| INSMED INC INSM | $115.2m10.04% | Reduced -40.9k |
| AMICUS THERAPEUTICS INC FOLD | $105.8m9.22% | Reduced -56.0k |
| STAAR SURGICAL CO STAA | $78.5m6.84% | Reduced -30.4k |
| BIOGEN INC BIIB | $73.6m6.42% | Unchanged |
| REVANCE THERAPEUTICS INC RVNC | $60.9m5.31% | Reduced -10.7k |
| PROTHENA CORP PLC PRTA | $45.7m3.98% | Unchanged |
| SAGE THERAPEUTICS INC SAGE | $27.5m2.40% | Reduced -310 |
| VANDA PHARMACEUTICALS INC VNDA | $27.2m2.37% | Unchanged |
| KARYOPHARM THERAPEUTICS INC COM | $25.4m2.21% | Unchanged |
| ACADIA PHARMACEUTICALS INC ACAD | $23.6m2.06% | Reduced -573.6k |
| ALKERMES PLC ALKS | $18.0m1.57% | Reduced -70.2k |
| EHEALTH INC EHTH | $15.4m1.35% | Added +2.4k |
| GOSSAMER BIO INC GOSS | $14.7m1.28% | Reduced -6.1k |
| SYNDAX PHARMACEUTICALS INC SNDX | $11.8m1.03% | Unchanged |
| ALIGN TECHNOLOGY INC ALGN | $10.5m0.91% | Unchanged |
| EPIZYME INC EPZM | $10.0m0.87% | Unchanged |
| ANAPTYSBIO INC ANAB | $8.8m0.76% | Unchanged |
| CLOVIS ONCOLOGY INC CLVS | $8.1m0.70% | Unchanged |
| GRITSTONE BIO INC GRTS | $5.6m0.49% | Unchanged |
| KEZAR LIFE SCIENCES INC COM | $5.4m0.47% | Unchanged |
| CYTOKINETICS INC CYTK | $4.4m0.38% | Unchanged |
| TRAVERE THERAPEUTICS INC TVTX | $4.0m0.35% | Unchanged |
| MIRUM PHARMACEUTICALS INC MIRM | $1.3m0.11% | Unchanged |
| ALIMERA SCIENCES INC ALIM | $1.1m0.10% | Unchanged |
| NOVAVAX INC NVAX | $643.0k0.06% | Unchanged |
| ALDEYRA THERAPEUTICS INC ALDX | $642.0k0.06% | Unchanged |
| MAGENTA THERAPEUTICS INC COM | $519.0k0.05% | Unchanged |
| UROGEN PHARMA LTD URGN | $201.0k0.02% | Unchanged |
| TACTILE SYS TECHNOLOGY INC TCMD | $198.0k0.02% | Unchanged |
| MARINUS PHARMACEUTICALS INC MRNS | $152.0k0.01% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| RIGEL PHARMACEUTICALS INC | $2.0m652.4k shares |
| KALEIDO BIOSCIENCES INC KLDO | $511.0k309.7k shares |